Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 5Withdrawn 1Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Genitourinary 1

Conditions

Mycoses 1Leukemia, Myeloid, Acute 1Genetic Predisposition to Disease 1Candidiasis 1Aspergillosis 1

Interventions

venetoclax 190Cyclophosphamide 123Azacitidine 112Cytarabine 108fludarabine 91Specimen Handling 74Biopsy 53Daunorubicin 42Methotrexate 41Dexamethasone 38Rituximab 34blinatumomab 32Vincristine 32Decitabine 31fludarabine phosphate 30Injections 28Granulocyte Colony-Stimulating Factor 28Whole-Body Irradiation 26Magnetic Resonance Spectroscopy 26obinutuzumab 25Idarubicin 25acalabrutinib 23Prednisone 23Mycophenolic Acid 23Melphalan 21Busulfan 21gilteritinib 19Mercaptopurine 19Doxorubicin 19ibrutinib 18

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Fluconazole × Other hematologic neoplasm × Clear all
NCT03828773 2025-12-09

PTX3AML

Centre Hospitalier Universitaire Vaudois

Phase NA Recruiting
410 enrolled
Other hematologic neoplasm

Aspergillosis, Candidiasis, Mycoses, Leukemia, Myeloid, Acute, Genetic Predisposition to Disease

Data powered by HemOnc (CC BY 4.0) Colophon âš¡